Abstract
Tuberculosis (TB) is of increasing concern due to the recent emergence and spread of MDR-TB, XDR-TB, TDR-TB and HIV/AIDS pandemic. There is urgent need for novel antitubercular agents which can shorten the treatment duration. Based on isosteric replacement and 3D structural similarity between Linezolid, an oxazolidine antimycobacterial agent, we have designed novel 4-amino-3,5-di(substituted)thiazolin-2(3H)thione/ones, synthesized and evaluated for their antimycobacterial activity on Mycobacterium tuberculosis H37Rv strain. Some of the compounds exhibited potent antimycobacterial activity with MIC values in the range of 1-2 µg/mL. Active compounds were further screened against MDR-TB and XDR-TB strain and found to exhibit promising in vitro activity.
Keywords: Antimycobacterial activity, MDR-TB, thiazolin-thione/ones, XDR-TB.
Anti-Infective Agents
Title:Synthesis and Antitubercular Activity of a Series of Thiazole Derivatives
Volume: 12 Issue: 2
Author(s): Mahesh Chhabria, Shailesh Patel, Sandeep Dholakia, Hardik Mistry and Sweta Patel
Affiliation:
Keywords: Antimycobacterial activity, MDR-TB, thiazolin-thione/ones, XDR-TB.
Abstract: Tuberculosis (TB) is of increasing concern due to the recent emergence and spread of MDR-TB, XDR-TB, TDR-TB and HIV/AIDS pandemic. There is urgent need for novel antitubercular agents which can shorten the treatment duration. Based on isosteric replacement and 3D structural similarity between Linezolid, an oxazolidine antimycobacterial agent, we have designed novel 4-amino-3,5-di(substituted)thiazolin-2(3H)thione/ones, synthesized and evaluated for their antimycobacterial activity on Mycobacterium tuberculosis H37Rv strain. Some of the compounds exhibited potent antimycobacterial activity with MIC values in the range of 1-2 µg/mL. Active compounds were further screened against MDR-TB and XDR-TB strain and found to exhibit promising in vitro activity.
Export Options
About this article
Cite this article as:
Chhabria Mahesh, Patel Shailesh, Dholakia Sandeep, Mistry Hardik and Patel Sweta, Synthesis and Antitubercular Activity of a Series of Thiazole Derivatives, Anti-Infective Agents 2014; 12 (2) . https://dx.doi.org/10.2174/22113525113119990119
DOI https://dx.doi.org/10.2174/22113525113119990119 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria
Current Topics in Medicinal Chemistry Pseudomonas aeruginosa Cif Defines a Distinct Class of α/β Epoxide Hydrolases Utilizing a His/Tyr Ring-Opening Pair
Protein & Peptide Letters Peptide Nucleic Acids (PNAs) as Diagnostic Devices for Genetic and Cytogenetic Analysis
Current Pharmaceutical Design Quality-by-design Enabled Chitosan Nanoparticles for Antitubercular Therapy: Formulation, Statistical Optimization, and <i>In Vitro</i> Characterization
Current Drug Therapy HIV-1 Infection In Children: A Clinical and Immunologic Overview
Current HIV Research Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Quinoxaline 1,4-di-N-Oxide and the Potential for Treating Tuberculosis
Infectious Disorders - Drug Targets Increasing Access to HIV Testing for Women by Simplifying Pre- and Post-Test Counseling
Current Women`s Health Reviews Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome
Current Drug Metabolism Drug Approval Process – In United States of America, European Union and India: A Review
Applied Clinical Research, Clinical Trials and Regulatory Affairs Synthesis of 1H-1,2,3-triazoles and Study of their Antifungal and Cytotoxicity Activities
Medicinal Chemistry Proteomic Analysis of Differentially Expressed Proteins in <i>Mycobacterium Tuberculosis</i>-Infected Macrophages
Current Proteomics Nano Particles: Emerging Warheads Against Bacterial Superbugs
Current Topics in Medicinal Chemistry Vitamin D: A Micronutrient Regulating Genes
Current Pharmaceutical Design Virtual Screening and in vitro Antibacterial Activity for the Identification of Novel Inhibitors of Mycobacterium tuberculosis Methionine Aminopeptidase
Current Enzyme Inhibition Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Peripheral Benzodiazepine Receptor Ligands and their Anti-Inflammatory Effects
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy Globalization of Clinical Trials – Where are We Heading?
Current Clinical Pharmacology Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews